Terms: = Leukemia AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967
8 results:
1. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S
Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401
[TBL] [Abstract] [Full Text] [Related]
2. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract] [Full Text] [Related]
3. The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral.
Osei-Sarfo K; Martello L; Ibrahim S; Pellicer A
Oncogene; 2011 Aug; 30(34):3661-71. PubMed ID: 21441953
[TBL] [Abstract] [Full Text] [Related]
4. Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.
Liedtke M; Ayton PM; Somervaille TC; Smith KS; Cleary ML
Blood; 2010 Jul; 116(1):63-70. PubMed ID: 20395419
[TBL] [Abstract] [Full Text] [Related]
5. Ras as a therapeutic target in hematologic malignancies.
Alvarado Y; Giles FJ
Expert Opin Emerg Drugs; 2007 May; 12(2):271-84. PubMed ID: 17604501
[TBL] [Abstract] [Full Text] [Related]
6. Thermodynamic and kinetic characterization of the interaction between the Ras binding domain of AF6 and members of the Ras subfamily.
Linnemann T; Geyer M; Jaitner BK; Block C; Kalbitzer HR; Wittinghofer A; Herrmann C
J Biol Chem; 1999 May; 274(19):13556-62. PubMed ID: 10224125
[TBL] [Abstract] [Full Text] [Related]
7. Methotrexate concentration levels in the cerebrospinal fluid during high-dose methotrexate infusions: an unreliable prediction.
Lippens RJ; Winograd B
Pediatr Hematol Oncol; 1988; 5(2):115-24. PubMed ID: 3152957
[TBL] [Abstract] [Full Text] [Related]
8. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
McKernan RM; Howard MJ; Motulsky HJ; Insel PA
Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
[TBL] [Abstract] [Full Text] [Related]
